EpiSign METRIC 5-base: A New Era for Episignature Analysis in Genomics#Canada#London#genomic_analysis#EpiSign#METRIC
EpiSign METRIC 5-base: A New Era for Episignature Analysis in Genomics
EpiSign Inc. has unveiled METRIC 5-base, enhancing episignature analysis across various genomic platforms. A breakthrough for genetic testing.
third-news.com
September 30, 2026 at 1:54 PM
EpiSign METRIC 5-base: A New Era for Episignature Analysis in Genomics#Canada#London#genomic_analysis#EpiSign#METRIC
June 13, 2026 at 9:42 AM
The availability of episignatures from #EpiSign are now displayed on gene pages and therapy tabs. Episignatures provide functional evidence to support variant interpretation and disease classification #RareDisease #VariantClassification
July 10, 2026 at 10:00 AM
The availability of episignatures from #EpiSign are now displayed on gene pages and therapy tabs. Episignatures provide functional evidence to support variant interpretation and disease classification #RareDisease #VariantClassification
Have you seen Bekim's early access presentation from ASHG? sapac.illumina.com/company/vide...
Low input, not HMW, not ultra pure extractions, high throughput, short read accuracy, cfDNA compatible and easy to use #DRAGEN analysis pipeline for those who don't have bioinformaticians on hand.
Low input, not HMW, not ultra pure extractions, high throughput, short read accuracy, cfDNA compatible and easy to use #DRAGEN analysis pipeline for those who don't have bioinformaticians on hand.
Sequencing reimagined—EpiSign validation of Illumina 5-base sequencing
sapac.illumina.com
February 18, 2026 at 11:30 PM
Have you seen Bekim's early access presentation from ASHG? sapac.illumina.com/company/vide...
Low input, not HMW, not ultra pure extractions, high throughput, short read accuracy, cfDNA compatible and easy to use #DRAGEN analysis pipeline for those who don't have bioinformaticians on hand.
Low input, not HMW, not ultra pure extractions, high throughput, short read accuracy, cfDNA compatible and easy to use #DRAGEN analysis pipeline for those who don't have bioinformaticians on hand.
Curious about the indications necessary to order #epigenetic testing❓
This #WorldEnvironmentDay, listen to our #sciencepodcast episode with Greenwood Genetic Center! 🧬
This #WorldEnvironmentDay, listen to our #sciencepodcast episode with Greenwood Genetic Center! 🧬
Epigenetics Podcast Interview — DNA Today
Hear about epigenetics in this 30 minute podcast interview. Discussion includes epigenetic disorders (Prader–Willi, Angelman, Beckwith-Wiedemann syndrome), testing for epigenetic (EpiSign), and…
dnapodcast.com
June 5, 2026 at 1:30 PM
Curious about the indications necessary to order #epigenetic testing❓
This #WorldEnvironmentDay, listen to our #sciencepodcast episode with Greenwood Genetic Center! 🧬
This #WorldEnvironmentDay, listen to our #sciencepodcast episode with Greenwood Genetic Center! 🧬
Feed: "EMBL"
By: Beatriz Allueva y Álava on Monday, July 13, 2026
By: Beatriz Allueva y Álava on Monday, July 13, 2026
DECIPHER v11.40 released
DECIPHER v11.40 is now available, featuring Regional Nonsense Constraint data, EpiSign™ episignatures, and updated NMD predictions
www.embl.org
July 14, 2026 at 12:38 PM
Feed: "EMBL"
By: Beatriz Allueva y Álava on Monday, July 13, 2026
By: Beatriz Allueva y Álava on Monday, July 13, 2026
"EpiSign can diagnose 19 diseases, for which methylation patterns have been established over the years." Including Prader-Willi and Angelman syndromes...
angelmansyndromenews.com/news/episign...
angelmansyndromenews.com/news/episign...
EpiSign Test Helps Make Accurate Diagnosis of Angelman, Other Diseases
Learn about EpiSign, a blood test that helps diagnose several diseases, including Angelman syndrome, based on epigenetic changes present in patients' cells.
angelmansyndromenews.com
January 2, 2025 at 10:58 PM
"EpiSign can diagnose 19 diseases, for which methylation patterns have been established over the years." Including Prader-Willi and Angelman syndromes...
angelmansyndromenews.com/news/episign...
angelmansyndromenews.com/news/episign...
Can't read the article, but curious if the authors have heard of EpiSign.
jmg.bmj.com/content/earl...
jmg.bmj.com/content/earl...
Long-read sequencing for detection and subtyping of Prader-Willi and Angelman syndromes
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are imprinting disorders caused by genetic or epigenetic aberrations of 15q11.2-q13. Their clinical testing is often multitiered; diagnostic test...
jmg.bmj.com
January 2, 2025 at 10:58 PM
Can't read the article, but curious if the authors have heard of EpiSign.
jmg.bmj.com/content/earl...
jmg.bmj.com/content/earl...
Honoured to host Minister Nolan Quinn at OBI with partners from EpiSign, CP-NET, SickKids & Holland Bloorview. A true reflection of our team science approach to improve brain health for the 1 in 3 affected. Thank you, Minister, and the Government of Ontario for your partnership & continued support!
May 28, 2025 at 2:56 PM
Honoured to host Minister Nolan Quinn at OBI with partners from EpiSign, CP-NET, SickKids & Holland Bloorview. A true reflection of our team science approach to improve brain health for the 1 in 3 affected. Thank you, Minister, and the Government of Ontario for your partnership & continued support!
EpiSign Inc. Unveils METRIC - A Revolutionary Software for Epigenomic Diagnostics#Canada#London#EpiSign#METRIC#epigenomics
EpiSign Inc. Unveils METRIC - A Revolutionary Software for Epigenomic Diagnostics
EpiSign Inc. has launched METRIC, a cutting-edge platform that enhances access to epigenomic diagnostics, transforming data into actionable insights for healthcare professionals.
third-news.com
October 15, 2025 at 1:04 PM
EpiSign Inc. Unveils METRIC - A Revolutionary Software for Epigenomic Diagnostics#Canada#London#EpiSign#METRIC#epigenomics
New finding from StefanBarakat on Twitter/X! rdcu.be/eyoik
New paper from our group on the clinical utility of DNA-methylation testing in daily clinical routine for diagnosis of rare disorders
t.co/3tg5sKtxyN
@ejhg_journal #EpiSign #n…
New paper from our group on the clinical utility of DNA-methylation testing in daily clinical routine for diagnosis of rare disorders
t.co/3tg5sKtxyN
@ejhg_journal #EpiSign #n…
t.co
July 30, 2025 at 8:32 AM
New finding from StefanBarakat on Twitter/X! rdcu.be/eyoik
New paper from our group on the clinical utility of DNA-methylation testing in daily clinical routine for diagnosis of rare disorders
t.co/3tg5sKtxyN
@ejhg_journal #EpiSign #n…
New paper from our group on the clinical utility of DNA-methylation testing in daily clinical routine for diagnosis of rare disorders
t.co/3tg5sKtxyN
@ejhg_journal #EpiSign #n…
